The BLOC1S1 Knockout HAP1 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population in which the BLOC1S1 gene (encoding biogenesis of lysosome-related organelles complex 1 subunit 1) has been disrupted in the HAP1 near-haploid human cell line. This polyclonal population serves as a loss-of-function model for investigating the roles of BLOC1S1 in endosomal-lysosomal trafficking and lysosome-related organelle biogenesis, without the need for single-cell cloning. The knockout is generated by CRISPR/Cas9-mediated gene disruption, resulting in a heterogeneous population of cells lacking wild-type BLOC1S1 protein expression, suitable for functional studies in a near-haploid genetic background.
HAP1 cells are a near-haploid human fibroblast-like cell line originally derived from KBM-7 chronic myeloid leukemia (CML) blast crisis cells. Their near-haploid karyotype eliminates the issue of allelic complexity, enabling unambiguous genotype-phenotype correlations and simplifying knockout generation. This cell line retains key features of somatic cells, including intact endosomal and lysosomal trafficking pathways, making it a robust platform for studying gene function in membrane trafficking processes. The BLOC1S1 knockout in HAP1 cells thus offers a genetically defined system to dissect the contribution of this subunit to the BLOC-1 complex and associated pathways.
BLOC1S1 is an essential subunit of the BLOC-1 complex, which functions in sorting membrane cargos from early endosomes to lysosome-related organelles such as melanosomes and platelet dense granules. The BLOC-1 complex interacts with the AP-3 complex and SNARE proteins including VAMP7 and syntaxin 13 to mediate vesicle docking and fusion. Upstream regulation involves membrane phosphatidylinositol-3-phosphate and small GTPases such as Rab32 and Rab38, which facilitate BLOC-1 recruitment. Downstream, BLOC-1-dependent trafficking delivers cargo like tyrosinase to melanosomes and serotonin/ADP to platelet dense granules. Disruption of BLOC1S1 uncouples these processes, recapitulating trafficking defects seen in Hermansky-Pudlak syndrome type 7.
In HAP1 cells, knockout of BLOC1S1 provides a physiologically relevant model to study lysosome-related organelle biogenesis and its associated diseases. The near-haploid background ensures complete gene disruption across the population without compensatory alleles, resulting in a consistent loss-of-function phenotype. This model enables detailed mechanistic studies of BLOC-1 complex assembly and function, as well as its interaction partners such as BLOC1S2-BLOC1S6 subunits and the AP-3 complex. It is particularly valuable for interrogating the molecular basis of Hermansky-Pudlak syndrome, a disorder characterized by defective biogenesis of melanosomes and platelet dense granules.
Researchers can employ this knockout model in a range of experimental settings, including western blotting to confirm loss of BLOC1S1 protein, immunofluorescence with lysosomal markers (LAMP1/2) to assess organelle morphology, and flow cytometry to measure lysosomal content. Functional assays such as lysosomal enzyme activity measurements, melanosome maturation assays based on tyrosinase activity, and platelet-like dense granule secretion studies can be performed in derivative systems. This product is also suited for drug screening aimed at identifying compounds that rescue trafficking defects in Hermansky-Pudlak syndrome or related disorders. For further technical information, please contact Ascent Research.
